Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors

Eitemau Tebyg

• Use of Second- and Third-Generation Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia: An Evolving Treatment Paradigm
  gan: Jabbour, Elias, et al.
  Cyhoeddwyd: (2015)
• Outcome After Failure of Second Generation Tyrosine Kinase Inhibitors Treatment As First-line Therapy for Patients With Chronic Myeloid Leukemia
  gan: Eghtedar, Alireza, et al.
  Cyhoeddwyd: (2013)
• Second-generation inhibitors of Bruton tyrosine kinase
  gan: Wu, Jingjing, et al.
  Cyhoeddwyd: (2016)
• Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
  gan: Westover, D, et al.
  Cyhoeddwyd: (2018)
• Upfront treatment with the first and second-generation tyrosine kinase inhibitors in Ph-positive acute lymphoblastic leukemia
  gan: Yu, Guopan, et al.
  Cyhoeddwyd: (2017)